nodes	percent_of_prediction	percent_of_DWPC	metapath
Mitomycin—stomach cancer—liver cancer	0.666	1	CtDrD
Mitomycin—POR—Doxorubicin—liver cancer	0.252	0.852	CbGbCtD
Mitomycin—ABCB1—Sorafenib—liver cancer	0.0272	0.0919	CbGbCtD
Mitomycin—ABCB1—Doxorubicin—liver cancer	0.0165	0.0558	CbGbCtD
Mitomycin—Metastatic disease—Epirubicin—liver cancer	0.00299	0.0773	CcSEcCtD
Mitomycin—Metastatic disease—Doxorubicin—liver cancer	0.00277	0.0715	CcSEcCtD
Mitomycin—Metastatic neoplasm—Epirubicin—liver cancer	0.0018	0.0465	CcSEcCtD
Mitomycin—Metastatic neoplasm—Doxorubicin—liver cancer	0.00166	0.043	CcSEcCtD
Mitomycin—Cardiotoxicity—Epirubicin—liver cancer	0.00146	0.0378	CcSEcCtD
Mitomycin—Cardiotoxicity—Doxorubicin—liver cancer	0.00135	0.035	CcSEcCtD
Mitomycin—Cardiac failure congestive—Sorafenib—liver cancer	0.000747	0.0193	CcSEcCtD
Mitomycin—Myelosuppression—Epirubicin—liver cancer	0.000735	0.019	CcSEcCtD
Mitomycin—Myelosuppression—Doxorubicin—liver cancer	0.00068	0.0176	CcSEcCtD
Mitomycin—Renal failure—Sorafenib—liver cancer	0.000513	0.0133	CcSEcCtD
Mitomycin—Stomatitis—Sorafenib—liver cancer	0.000509	0.0131	CcSEcCtD
Mitomycin—Burning sensation—Epirubicin—liver cancer	0.000496	0.0128	CcSEcCtD
Mitomycin—Haematemesis—Epirubicin—liver cancer	0.000496	0.0128	CcSEcCtD
Mitomycin—Haematemesis—Doxorubicin—liver cancer	0.000459	0.0119	CcSEcCtD
Mitomycin—Burning sensation—Doxorubicin—liver cancer	0.000459	0.0119	CcSEcCtD
Mitomycin—Necrosis—Epirubicin—liver cancer	0.000439	0.0113	CcSEcCtD
Mitomycin—Stinging—Epirubicin—liver cancer	0.000426	0.011	CcSEcCtD
Mitomycin—Alopecia—Sorafenib—liver cancer	0.000414	0.0107	CcSEcCtD
Mitomycin—Erythema—Sorafenib—liver cancer	0.000408	0.0105	CcSEcCtD
Mitomycin—Necrosis—Doxorubicin—liver cancer	0.000406	0.0105	CcSEcCtD
Mitomycin—Extravasation—Epirubicin—liver cancer	0.000395	0.0102	CcSEcCtD
Mitomycin—Stinging—Doxorubicin—liver cancer	0.000394	0.0102	CcSEcCtD
Mitomycin—Anaemia—Sorafenib—liver cancer	0.000377	0.00974	CcSEcCtD
Mitomycin—Syncope—Sorafenib—liver cancer	0.000366	0.00945	CcSEcCtD
Mitomycin—Extravasation—Doxorubicin—liver cancer	0.000366	0.00945	CcSEcCtD
Mitomycin—Leukopenia—Sorafenib—liver cancer	0.000365	0.00943	CcSEcCtD
Mitomycin—Ulcer—Epirubicin—liver cancer	0.000364	0.00942	CcSEcCtD
Mitomycin—Loss of consciousness—Sorafenib—liver cancer	0.000358	0.00926	CcSEcCtD
Mitomycin—Cough—Sorafenib—liver cancer	0.000356	0.0092	CcSEcCtD
Mitomycin—Hypertension—Sorafenib—liver cancer	0.000352	0.0091	CcSEcCtD
Mitomycin—Injection site reaction—Epirubicin—liver cancer	0.000343	0.00886	CcSEcCtD
Mitomycin—Ulcer—Doxorubicin—liver cancer	0.000337	0.00871	CcSEcCtD
Mitomycin—Shock—Sorafenib—liver cancer	0.000327	0.00846	CcSEcCtD
Mitomycin—Thrombocytopenia—Sorafenib—liver cancer	0.000326	0.00842	CcSEcCtD
Mitomycin—Anorexia—Sorafenib—liver cancer	0.000317	0.0082	CcSEcCtD
Mitomycin—Injection site reaction—Doxorubicin—liver cancer	0.000317	0.00819	CcSEcCtD
Mitomycin—Pulmonary oedema—Epirubicin—liver cancer	0.000307	0.00793	CcSEcCtD
Mitomycin—Dyspnoea—Sorafenib—liver cancer	0.000297	0.00767	CcSEcCtD
Mitomycin—Decreased appetite—Sorafenib—liver cancer	0.000289	0.00748	CcSEcCtD
Mitomycin—Thrombophlebitis—Epirubicin—liver cancer	0.000289	0.00747	CcSEcCtD
Mitomycin—Fatigue—Sorafenib—liver cancer	0.000287	0.00741	CcSEcCtD
Mitomycin—Pain—Sorafenib—liver cancer	0.000285	0.00735	CcSEcCtD
Mitomycin—Pulmonary oedema—Doxorubicin—liver cancer	0.000284	0.00734	CcSEcCtD
Mitomycin—Cardiac failure congestive—Epirubicin—liver cancer	0.000276	0.00713	CcSEcCtD
Mitomycin—Thrombophlebitis—Doxorubicin—liver cancer	0.000267	0.00691	CcSEcCtD
Mitomycin—Body temperature increased—Sorafenib—liver cancer	0.000263	0.0068	CcSEcCtD
Mitomycin—Renal impairment—Epirubicin—liver cancer	0.000263	0.00679	CcSEcCtD
Mitomycin—Cardiac failure congestive—Doxorubicin—liver cancer	0.000255	0.0066	CcSEcCtD
Mitomycin—Renal impairment—Doxorubicin—liver cancer	0.000243	0.00629	CcSEcCtD
Mitomycin—Asthenia—Sorafenib—liver cancer	0.000239	0.00617	CcSEcCtD
Mitomycin—Diarrhoea—Sorafenib—liver cancer	0.000228	0.00588	CcSEcCtD
Mitomycin—Dizziness—Sorafenib—liver cancer	0.00022	0.00569	CcSEcCtD
Mitomycin—Vomiting—Sorafenib—liver cancer	0.000212	0.00547	CcSEcCtD
Mitomycin—Rash—Sorafenib—liver cancer	0.00021	0.00542	CcSEcCtD
Mitomycin—Dermatitis—Sorafenib—liver cancer	0.00021	0.00542	CcSEcCtD
Mitomycin—Headache—Sorafenib—liver cancer	0.000208	0.00539	CcSEcCtD
Mitomycin—Pancytopenia—Epirubicin—liver cancer	0.000205	0.00531	CcSEcCtD
Mitomycin—Nausea—Sorafenib—liver cancer	0.000198	0.00511	CcSEcCtD
Mitomycin—Drowsiness—Epirubicin—liver cancer	0.000193	0.00498	CcSEcCtD
Mitomycin—Pancytopenia—Doxorubicin—liver cancer	0.00019	0.00491	CcSEcCtD
Mitomycin—Renal failure—Epirubicin—liver cancer	0.00019	0.0049	CcSEcCtD
Mitomycin—Stomatitis—Epirubicin—liver cancer	0.000188	0.00486	CcSEcCtD
Mitomycin—Drowsiness—Doxorubicin—liver cancer	0.000178	0.00461	CcSEcCtD
Mitomycin—Renal failure—Doxorubicin—liver cancer	0.000175	0.00453	CcSEcCtD
Mitomycin—Stomatitis—Doxorubicin—liver cancer	0.000174	0.00449	CcSEcCtD
Mitomycin—Alopecia—Epirubicin—liver cancer	0.000153	0.00395	CcSEcCtD
Mitomycin—Erythema—Epirubicin—liver cancer	0.000151	0.00389	CcSEcCtD
Mitomycin—Vision blurred—Epirubicin—liver cancer	0.000142	0.00367	CcSEcCtD
Mitomycin—Alopecia—Doxorubicin—liver cancer	0.000142	0.00366	CcSEcCtD
Mitomycin—Ill-defined disorder—Epirubicin—liver cancer	0.00014	0.00361	CcSEcCtD
Mitomycin—Erythema—Doxorubicin—liver cancer	0.000139	0.0036	CcSEcCtD
Mitomycin—Anaemia—Epirubicin—liver cancer	0.000139	0.0036	CcSEcCtD
Mitomycin—Malaise—Epirubicin—liver cancer	0.000136	0.00351	CcSEcCtD
Mitomycin—Syncope—Epirubicin—liver cancer	0.000135	0.00349	CcSEcCtD
Mitomycin—Leukopenia—Epirubicin—liver cancer	0.000135	0.00349	CcSEcCtD
Mitomycin—Loss of consciousness—Epirubicin—liver cancer	0.000132	0.00342	CcSEcCtD
Mitomycin—Cough—Epirubicin—liver cancer	0.000131	0.0034	CcSEcCtD
Mitomycin—Vision blurred—Doxorubicin—liver cancer	0.000131	0.0034	CcSEcCtD
Mitomycin—Hypertension—Epirubicin—liver cancer	0.00013	0.00336	CcSEcCtD
Mitomycin—Ill-defined disorder—Doxorubicin—liver cancer	0.000129	0.00334	CcSEcCtD
Mitomycin—Anaemia—Doxorubicin—liver cancer	0.000129	0.00333	CcSEcCtD
Mitomycin—Discomfort—Epirubicin—liver cancer	0.000127	0.00328	CcSEcCtD
Mitomycin—Malaise—Doxorubicin—liver cancer	0.000126	0.00325	CcSEcCtD
Mitomycin—Syncope—Doxorubicin—liver cancer	0.000125	0.00323	CcSEcCtD
Mitomycin—Leukopenia—Doxorubicin—liver cancer	0.000125	0.00323	CcSEcCtD
Mitomycin—Confusional state—Epirubicin—liver cancer	0.000124	0.0032	CcSEcCtD
Mitomycin—Oedema—Epirubicin—liver cancer	0.000123	0.00318	CcSEcCtD
Mitomycin—Loss of consciousness—Doxorubicin—liver cancer	0.000123	0.00317	CcSEcCtD
Mitomycin—Cough—Doxorubicin—liver cancer	0.000122	0.00314	CcSEcCtD
Mitomycin—Shock—Epirubicin—liver cancer	0.000121	0.00313	CcSEcCtD
Mitomycin—Thrombocytopenia—Epirubicin—liver cancer	0.00012	0.00311	CcSEcCtD
Mitomycin—Hypertension—Doxorubicin—liver cancer	0.00012	0.00311	CcSEcCtD
Mitomycin—Discomfort—Doxorubicin—liver cancer	0.000117	0.00303	CcSEcCtD
Mitomycin—Anorexia—Epirubicin—liver cancer	0.000117	0.00303	CcSEcCtD
Mitomycin—Confusional state—Doxorubicin—liver cancer	0.000115	0.00297	CcSEcCtD
Mitomycin—Oedema—Doxorubicin—liver cancer	0.000114	0.00294	CcSEcCtD
Mitomycin—Shock—Doxorubicin—liver cancer	0.000112	0.00289	CcSEcCtD
Mitomycin—Thrombocytopenia—Doxorubicin—liver cancer	0.000111	0.00288	CcSEcCtD
Mitomycin—Dyspnoea—Epirubicin—liver cancer	0.00011	0.00283	CcSEcCtD
Mitomycin—Somnolence—Epirubicin—liver cancer	0.000109	0.00283	CcSEcCtD
Mitomycin—Anorexia—Doxorubicin—liver cancer	0.000108	0.0028	CcSEcCtD
Mitomycin—Decreased appetite—Epirubicin—liver cancer	0.000107	0.00276	CcSEcCtD
Mitomycin—Fatigue—Epirubicin—liver cancer	0.000106	0.00274	CcSEcCtD
Mitomycin—Pain—Epirubicin—liver cancer	0.000105	0.00272	CcSEcCtD
Mitomycin—Dyspnoea—Doxorubicin—liver cancer	0.000101	0.00262	CcSEcCtD
Mitomycin—Feeling abnormal—Epirubicin—liver cancer	0.000101	0.00262	CcSEcCtD
Mitomycin—Somnolence—Doxorubicin—liver cancer	0.000101	0.00261	CcSEcCtD
Mitomycin—Decreased appetite—Doxorubicin—liver cancer	9.89e-05	0.00256	CcSEcCtD
Mitomycin—Fatigue—Doxorubicin—liver cancer	9.81e-05	0.00254	CcSEcCtD
Mitomycin—Pain—Doxorubicin—liver cancer	9.73e-05	0.00251	CcSEcCtD
Mitomycin—Body temperature increased—Epirubicin—liver cancer	9.72e-05	0.00251	CcSEcCtD
Mitomycin—Feeling abnormal—Doxorubicin—liver cancer	9.38e-05	0.00242	CcSEcCtD
Mitomycin—Body temperature increased—Doxorubicin—liver cancer	9e-05	0.00232	CcSEcCtD
Mitomycin—Asthenia—Epirubicin—liver cancer	8.82e-05	0.00228	CcSEcCtD
Mitomycin—Diarrhoea—Epirubicin—liver cancer	8.41e-05	0.00217	CcSEcCtD
Mitomycin—Asthenia—Doxorubicin—liver cancer	8.16e-05	0.00211	CcSEcCtD
Mitomycin—Dizziness—Epirubicin—liver cancer	8.13e-05	0.0021	CcSEcCtD
Mitomycin—Vomiting—Epirubicin—liver cancer	7.82e-05	0.00202	CcSEcCtD
Mitomycin—Diarrhoea—Doxorubicin—liver cancer	7.79e-05	0.00201	CcSEcCtD
Mitomycin—Rash—Epirubicin—liver cancer	7.75e-05	0.002	CcSEcCtD
Mitomycin—Dermatitis—Epirubicin—liver cancer	7.75e-05	0.002	CcSEcCtD
Mitomycin—Headache—Epirubicin—liver cancer	7.7e-05	0.00199	CcSEcCtD
Mitomycin—Dizziness—Doxorubicin—liver cancer	7.53e-05	0.00194	CcSEcCtD
Mitomycin—Nausea—Epirubicin—liver cancer	7.31e-05	0.00189	CcSEcCtD
Mitomycin—Vomiting—Doxorubicin—liver cancer	7.24e-05	0.00187	CcSEcCtD
Mitomycin—Rash—Doxorubicin—liver cancer	7.18e-05	0.00185	CcSEcCtD
Mitomycin—Dermatitis—Doxorubicin—liver cancer	7.17e-05	0.00185	CcSEcCtD
Mitomycin—Headache—Doxorubicin—liver cancer	7.13e-05	0.00184	CcSEcCtD
Mitomycin—Nausea—Doxorubicin—liver cancer	6.76e-05	0.00175	CcSEcCtD
